|
1）Peterson CT, Sharma V, Elmén L, et al. Immune homeostasis, fysbiosis and therapeutic modulation of the gut microbiota. Clin Exp Immunol. 2015; 179: 363-77
|
|
|
|
2）Bianconi E, Piovesan A, Facchin F, et al. An estimation of the number of cells in the human body. Ann Hum Biol. 2013; 40: 463-71
|
|
|
|
|
|
3）Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010; 464: 59-65
|
|
|
|
|
|
4）Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011; 473: 174-80
|
|
|
|
|
|
5）Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490: 55-60
|
|
|
|
|
|
6）Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013; 498: 99-103
|
|
|
|
|
|
7）Qin N, Yang G, Li A, et al. Alterations of the hum- an gut microbiome in liver cirrhosis. Nature. 2014; 413: 59-64
|
|
|
|
|
|
8）Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491:119-24
|
|
|
|
|
|
9）Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014; 146: 1489-99
|
|
|
|
|
|
10）Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009; 7: 887-94
|
|
|
|
|
|
11）Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohnʼs disease. Cell Host Microbe. 2014; 15: 382-92
|
|
|
|
|
|
12）Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009; 457: 480-4
|
|
|
|
|
|
13）Ley RE, Bäckhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005; 102: 11070-5
|
|
|
|
|
|
14）Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444: 1027-31
|
|
|
|
|
|
15）Ferrer M, Ruiz A, Lanza F, et al. Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Environ Microbiol. 2013; 15: 211-26
|
|
|
|
|
|
16）Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444: 1022-3
|
|
|
|
|
|
17）Alang N, Kelly CR. Weight gain after fecal microbiota transplantation. Open Forum Infect Dis. 2015; 2: ofv004
|
|
|
|
|
|
18）Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterol. 2009; 137: 1716-24
|
|
|
|
|
|
19）Shin NR, Lee JC, Lee HY, et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 2014; 63: 727-35
|
|
|
|
|
|
20）Lee H, Ko G. Effect of metformin on metabolic improvement and gut microbiota. Appl Environ Microbiol. 2014; 80: 5935-43
|
|
|
|
|
|
21）Zhang X, Zhao Y, Xu J, et al. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Sci Rep. 2015; 5: 14405
|
|
|
|
|
|
22）Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013; 110: 9066-71
|
|
|
|
|
|
23）Henao-Mejia J, Elinav E, Jin CC, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012; 482: 179-85
|
|
|
|
|
|
24）Le Roy T, Llopis M, Lepage P, et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut. 2013; 62: 1787-94
|
|
|
|
|
|
25）Buchman AL, Dubin MD, Moukarzel AA, et al. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology (Baltimore, MD). 1995; 22: 1399-403
|
|
|
|
|
|
26）Spencer MD, Hamp TJ, Reid RW, et al. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology. 2011; 140: 976-86
|
|
|
|
|
|
27）Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology. 2013; 57: 601-9
|
|
|
|
|
|
28）Wong VWS, Tse CH, Lam TTY, et al. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis - a longitudinal study. PLoS One. 2013; 8: e62885
|
|
|
|
|